Both sides now: losses and gains of mutant CALR

被引：3

作者：

Mullally, Ann ^{[1
]}

机构：

[1] Harvard Med Sch, Boston, MA 02115 USA

来源：

BLOOD | 2020年 / 135卷 / 02期

关键词：

THROMBOPOIETIN RECEPTOR; CALRETICULIN; ACTIVATION; MUTATIONS;

D O I：

10.1182/blood.2019003820

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this issue of Blood, Di Buduo et al report on the consequences of loss of the interaction between mutant calreticulin (CALR) and endoplasmic reticulum (ER) resident protein 57 (ERp57) as it pertains to altered calcium signaling in myeloproliferative neoplasms (MPNs).(1)

引用

页码：82 / 83

页数：2

共 10 条

[1] Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms [J].

Araki, Marito ;

Yang, Yinjie ;

Masubuchi, Nami ;

Hironaka, Yumi ;

Takei, Hiraku ;

Morishita, Soji ;

Mizukami, Yoshihisa ;

Kan, Shin ;

Shirane, Shuichi ;

Edahiro, Yoko ;

Sunami, Yoshitaka ;

Ohsaka, Akimichi ;

Komatsu, Norio .

BLOOD, 2016, 127 (10) :1307-1316

[2] Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants [J].

Chachoua, Ilyas ;

Pecquet, Christian ;

El-Khoury, Mira ;

Nivarthi, Harini ;

Albu, Roxana-Irina ;

Marty, Caroline ;

Gryshkova, Vitalina ;

Defour, Jean-Philippe ;

Vertenoeil, Gaelle ;

Ngo, Anna ;

Koay, Ann ;

Raslova, Hana ;

Courtoy, Pierre J. ;

Choong, Meng Ling ;

Plo, Isabelle ;

Vainchenker, William ;

Kralovics, Robert ;

Constantinescu, Stefan N. .

BLOOD, 2016, 127 (10) :1325-1335

[3] Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms [J].

Di Buduo, Christian A. ;

Abbonante, Vittorio ;

Marty, Caroline ;

Moccia, Francesco ;

Rumi, Elisa ;

Pietra, Daniela ;

Soprano, Paolo M. ;

Lim, Dmitry ;

Cattaneo, Daniele ;

Iurlo, Alessandra ;

Gianelli, Umberto ;

Barosi, Giovanni ;

Rosti, Vittorio ;

Plo, Isabelle ;

Cazzola, Mario ;

Balduini, Alessandra .

BLOOD, 2020, 135 (02) :133-144

[4] Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN [J].

Elf, Shannon ;

Abdelfattah, Nouran S. ;

Baral, April J. ;

Beeson, Danielle ;

Rivera, Jeanne F. ;

Ko, Amy ;

Florescu, Natalie ;

Birrane, Gabriel ;

Chen, Edwin ;

Mullally, Ann .

BLOOD, 2018, 131 (07) :782-786

[5] Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation [J].

Elf, Shannon ;

Abdelfattah, Nouran S. ;

Chen, Edwin ;

Perales-Paton, Javier ;

Rosen, Emily A. ;

Ko, Amy ;

Peisker, Fabian ;

Florescu, Natalie ;

Giannini, Silvia ;

Wolach, Ofir ;

Morgan, Elizabeth A. ;

Tothova, Zuzana ;

Losman, Julie-Aurore ;

Schneider, Rebekka K. ;

Al-Shahrour, Fatima ;

Mullally, Ann .

CANCER DISCOVERY, 2016, 6 (04) :368-381

[6] Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms [J].

Klampfl, Thorsten ;

Gisslinger, Heinz ;

Harutyunyan, Ashot S. ;

Nivarthi, Harini ;

Rumi, Elisa ;

Milosevic, Jelena D. ;

Them, Nicole C. C. ;

Berg, Tiina ;

Gisslinger, Bettina ;

Pietra, Daniela ;

Chen, Doris ;

Vladimer, Gregory I. ;

Bagienski, Klaudia ;

Milanesi, Chiara ;

Casetti, Ilaria Carola ;

Sant'Antonio, Emanuela ;

Ferretti, Virginia ;

Elena, Chiara ;

Schischlik, Fiorella ;

Cleary, Ciara ;

Six, Melanie ;

Schalling, Martin ;

Schoenegger, Andreas ;

Bock, Christoph ;

Malcovati, Luca ;

Pascutto, Cristiana ;

Superti-Furga, Giulio ;

Cazzola, Mario ;

Kralovics, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2379-2390

[7] Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2 [J].

Nangalia, J. ;

Massie, C. E. ;

Baxter, E. J. ;

Nice, F. L. ;

Gundem, G. ;

Wedge, D. C. ;

Avezov, E. ;

Li, J. ;

Kollmann, K. ;

Kent, D. G. ;

Aziz, A. ;

Godfrey, A. L. ;

Hinton, J. ;

Martincorena, I. ;

Van Loo, P. ;

Jones, A. V. ;

Guglielmelli, P. ;

Tarpey, P. ;

Harding, H. P. ;

Fitzpatrick, J. D. ;

Goudie, C. T. ;

Ortmann, C. A. ;

Loughran, S. J. ;

Raine, K. ;

Jones, D. R. ;

Butler, A. P. ;

Teague, J. W. ;

O'Meara, S. ;

McLaren, S. ;

Bianchi, M. ;

Silber, Y. ;

Dimitropoulou, D. ;

Bloxham, D. ;

Mudie, L. ;

Maddison, M. ;

Robinson, B. ;

Keohane, C. ;

Maclean, C. ;

Hill, K. ;

Orchard, K. ;

Tauro, S. ;

Du, M-Q ;

Greaves, M. ;

Bowen, D. ;

Huntly, B. J. P. ;

Harrison, C. N. ;

Cross, N. C. P. ;

Ron, D. ;

Vannucchi, A. M. ;

Papaemmanuil, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2391-2405

[8] Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms [J].

Pietra, D. ;

Rumi, E. ;

Ferretti, V. V. ;

Di Buduo, C. A. ;

Milanes, C. ;

Cavalloni, C. ;

Sant'Antonio, E. ;

Abbonante, V. ;

Moccia, F. ;

Casetti, I. C. ;

Bellini, M. ;

Renna, M. C. ;

Roncoroni, E. ;

Fugazza, E. ;

Astori, C. ;

Boveri, E. ;

Rosti, V. ;

Barosi, G. ;

Balduini, A. ;

Cazzola, M. .

LEUKEMIA, 2016, 30 (02) :431-438

[9] Targeting the CALR interactome in myeloproliferative neoplasms [J].

Pronier, Elodie ;

Cifani, Paolo ;

Merlinsky, Tiffany R. ;

Berman, Katharine Barr ;

Somasundara, Amritha Varshini Hanasoge ;

Rampal, Uraajit K. ;

LaCava, John ;

Wei, Karen E. ;

Pastore, Friederike ;

Maag, Jesper L., V ;

Park, Jane ;

Koche, Richard ;

Kentsis, Alex ;

Levine, Ross L. .

JCI INSIGHT, 2018, 3 (22)

[10] Calcium signaling and cell proliferation [J].

Xavier Pinto, Mauro Cunha ;

Kihara, Alexandre Hiroaki ;

Goulart, Vania A. M. ;

Tonelli, Fernanda M. P. ;

Gomes, Katia N. ;

Ulrich, Henning ;

Resende, Rodrigo R. .

CELLULAR SIGNALLING, 2015, 27 (11) :2139-2149

← 1 →